Avadel Pharmaceuticals plc ( AVDL) - Key Metrics
Stock symbol AVDL is outdated, potentially delisted? Maybe it is available on other exchange?
AVDL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.70 | $0.10 | $0.13 | $0.13 |
| 2025Q1 | $0.54 | -$0.05 | -$0.09 | -$0.09 |
| 2024Q4 | $0.52 | -$0.05 | $0.08 | $0.08 |
| 2024Q3 | $0.52 | -$0.03 | -$0.07 | -$0.07 |
| 2024Q2 | $0.43 | -$0.14 | -$0.19 | -$0.19 |
AVDL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | 22.14 |
| 2025Q1 | ? | -38.43 |
| 2024Q4 | ? | -50.22 |
| 2024Q3 | ? | -120.33 |
| 2024Q2 | ? | -24.56 |
AVDL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 1.46% | ? |
| 2025Q1 | -1.09% | ? |
| 2024Q4 | 0.78% | ? |
| 2024Q3 | -0.55% | ? |
| 2024Q2 | -1.34% | ? |
AVDL
Price: $21.64
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -1084.50
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Ireland
Volume: 237800
Ebitda: 27.2 millionMarket Capitalization: 2.1 billion